Related Experiment Videos
Mitogen-activated protein kinases and asthma.
Girolamo Pelaia1, Giovanni Cuda, Alessandro Vatrella
1Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Italy. pelaia@unicz.it
Journal of Cellular Physiology
|August 19, 2004
Summary
Mitogen-activated protein kinases (MAPKs) are crucial enzymes in asthma development. Targeting MAPKs offers a promising strategy for developing new anti-asthma medications.
Area of Science:
- Biochemistry
- Immunology
- Pharmacology
Background:
- Mitogen-activated protein kinases (MAPKs) are vital enzymes in cellular signal transduction.
- Extracellular stimuli in airways trigger inflammatory and structural changes characteristic of asthma.
- MAPKs are central to various signaling pathways influencing airway function and asthma.
Purpose of the Study:
- To review the critical role of MAPKs in asthma pathogenesis.
- To explore the potential of MAPKs as therapeutic targets for asthma treatment.
Main Methods:
- Literature review of MAPK involvement in asthma.
- Analysis of signaling pathways affected by MAPKs in airway inflammation and remodeling.
Main Results:
- MAPKs mediate key inflammatory processes in asthma, including T cell activation and immune cell infiltration.
- MAPKs contribute significantly to airway hyperresponsiveness and structural remodeling in asthma.
- MAPKs are implicated in diverse signaling cascades relevant to asthma pathophysiology.
Conclusions:
- MAPKs play a pivotal role in the development and progression of asthma.
- Targeting MAPKs presents a promising avenue for novel anti-asthma drug development.